← Back to headlines
AstraZeneca-Amgen Asthma Drug Shows Success in Late-Stage Esophageal Disease Trial
A joint asthma medication developed by AstraZeneca and Amgen has successfully passed late-stage clinical trials for treating esophageal disease, marking a significant therapeutic advancement.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
